NCT07426484 2026-02-23
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Phase 4 Not yet recruiting
Dana-Farber Cancer Institute
Eli Lilly and Company
Gadjah Mada University
Nanfang Hospital, Southern Medical University
University Hospital, Grenoble
IRCCS San Raffaele